Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Vertex Pharmaceuticals identifies new SERPINA1 polymerization inhibitors

Oct. 28, 2021

New TYK2 inhibitors synthesized at Eternity Bioscience

Oct. 27, 2021

Vertex Pharmaceuticals discovers alpha-1-antitrypsin (Z-mutant) polymerization inhibitors

Oct. 27, 2021

Global Blood Therapeutics patents pyruvate kinase activators

Oct. 27, 2021

Stealth BioTherapeutics describes compounds for treating mitochondrial disease

Oct. 27, 2021

New tyrosine-protein kinase CSK inhibitors identified at Plexxikon

Oct. 27, 2021

Kinsensus Limited describes new MERTK/AXL inhibitors

Oct. 26, 2021

New HLA-DRB1 ligands identified at Janssen Pharmaceutica

Oct. 26, 2021

New CD80/PD-L1 and/or PD-1/PD-L1 interaction inhibitors discovered at Bristol Myers Squibb

Oct. 26, 2021

Thomas Jefferson University, Context Therapeutics patent androgen and SIGMAR1 receptor antagonists

Oct. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 17, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...